Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Silvio Inzucchi MD
Silvio E. Inzucchi MD Editor-in-Chief
Kathleen Dungan MD, MPH
Kathleen M. Dungan MD, MPH Advisory Board
Richard Pratley MD
Richard E. Pratley MD Associate Editor
See All Experts
featured
Published in Diabetes

Journal Scan / Research · October 29, 2024

Effects of GLP-1 Receptor Agonists Used as an Adjunct to Insulin Therapy on HbA1c Levels and CGM Metrics in Adults With Type 1 Diabetes

Diabetes, Obesity & Metabolism

 

 Save  Recommend
 Share

Additional Info

Disclosure statements are available on the authors' profiles:

Carolina Gonzalez-Lopez MD

Diabetes, Obesity & Metabolism
Effects of glucagon-like peptide-1 receptor agonists on glycated haemoglobin and continuous glucose monitoring metrics as adjunctive therapy to insulin in adults with type 1 diabetes: A meta-analysis of randomized controlled trials
Diabetes Obes Metab 2024 Sep 30;[EPub Ahead of Print], P Karakasis, T Koufakis, D Patoulias, F Barkas, A Klisic, M Mitrovic, M Doumas, N Papanas, DS Popovic

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading

Most Read This Week

Recently Updated